Rory B. Riggs
Known title: DirectorCIK: 0001016835
Rory B. Riggs's purchase track record
Rory B. Riggs has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/12/2023 | CBUS | $5.47M | +73.7% | -4.1% | +15.8% |
| 6/1/2023 | CBUS | $32K | -43.7% | -51.7% | +8.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Royalty Pharma Declares Q4 2026 Dividend. Royalty Pharma announced its fourth-quarter 2026 dividend, a routine move that supports its status as a consistent income provider with a yield near 3%. Recent commentary also highlights the company's valuation metrics, noting that its multiples may offer an attractive risk-reward balance for some market participants. The stock currently trades within its 52-week range, with analysts maintaining a consensus target price above current levels.
Transaction History
| CBUS | ▲ Buy | Grant | 333,333 | $500K | 1/29/2026 | View on chart |
| CBUS | ▼ Sell | Other | 4,000,000 | $400 | 6/9/2025 | View on chart |
| CBUS | ▼ Sell | Other | 50,000 | $500 | 6/9/2025 | View on chart |
| CBUS | ▲ Buy | Grant | 5,714,286 | $10.0M | 6/5/2025 | View on chart |
| CBUS | ▼ Sell | Other | 1,388,084 | — | 12/31/2024 | View on chart |
| CBUS | ▼ Sell | Other | 1,388,084 | — | 12/31/2024 | View on chart |
| CBUS | ▲ Buy | Grant | 250,000 | $1.0M | 9/18/2024 | View on chart |
| CBUS | ▲ Buy | Grant | 98,040 | $1.0M | 6/11/2024 | View on chart |
| RPRX | ▼ Sell | Other | 300,000 | $0 | 2/20/2024 | View on chart |
| RPRX | ▼ Sell | Open Market | 35,702 | $984K | 1/4/2024 | View on chart |
| RPRX | ▼ Sell | Open Market | 199,098 | $5.5M | 1/3/2024 | View on chart |
| RPRX | ▼ Sell | Open Market | 235,200 | $6.7M | 1/2/2024 | View on chart |
| CBUS | ▼ Sell | Other | 1,505,967 | $0 | 12/29/2023 | View on chart |
| CBUS | ▼ Sell | Other | 1,500,000 | $0 | 12/29/2023 | View on chart |
| CBUS | ▼ Sell | Other | 1,500,000 | $0 | 12/29/2023 | View on chart |
| CBUS | ▲ Buy | Open Market | 517,107 | $5.5M | 12/12/2023 | View on chart |
| RPRX | ▼ Sell | Other | 475,590 | $0 | 11/13/2023 | View on chart |
| CBUS | ▼ Sell | Other | 39,476 | $0 | 9/27/2023 | View on chart |
| RPRX | ▲ Buy | Grant | 7,747 | $0 | 6/23/2023 | View on chart |
| CBUS | ▲ Buy | Open Market | 1,000 | $32K | 6/1/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 9,600 | — | 5/31/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 848,662 | — | 5/31/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 2,916 | — | 5/31/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 118,893 | — | 5/31/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 5,401 | — | 5/31/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 167,992 | — | 5/31/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 1,361,226 | — | 5/31/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 20,891 | — | 5/31/2023 | View on chart |
| CBUS | ▲ Buy | Grant | 1,505,967 | — | 5/31/2023 | View on chart |
| RPRX | ▼ Sell | Open Market | 1,750,000 | $57.4M | 5/22/2023 | View on chart |
| RPRX | ▼ Sell | Other | 300,000 | $0 | 5/9/2023 | View on chart |
| RPRX | ▼ Sell | Open Market | 130,024 | $4.7M | 3/30/2023 | View on chart |
| RPRX | ▼ Sell | Open Market | 9,926 | $367K | 3/29/2023 | View on chart |
| RPRX | ▼ Sell | Other | 1,500,000 | $0 | 2/17/2023 | View on chart |
| RPRX | ▼ Sell | Open Market | 19,990 | $841K | 12/9/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 120,000 | $5.1M | 11/17/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 52,025 | $2.2M | 9/15/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 47,975 | $2.0M | 9/14/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 45,000 | $2.0M | 8/9/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 30,000 | $1.3M | 6/29/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 123,696 | $4.9M | 5/20/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 26,304 | $1.1M | 5/19/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 60,000 | $2.3M | 3/29/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 25,545 | $998K | 3/21/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 14,322 | $559K | 3/21/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 46,803 | $1.8M | 3/18/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 26,238 | $1.0M | 3/18/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 56,181 | $2.2M | 3/18/2022 | View on chart |
| RPRX | ▼ Sell | Other | 4,897 | — | 3/17/2022 | View on chart |
| RPRX | ▼ Sell | Other | 64,067 | — | 3/17/2022 | View on chart |
| RPRX | ▼ Sell | Other | 229,626 | — | 3/17/2022 | View on chart |
| RPRX | ▼ Sell | Other | 1,075,178 | — | 3/17/2022 | View on chart |
| RPRX | ▼ Sell | Other | 531,684 | — | 3/17/2022 | View on chart |
| RPRX | ▼ Sell | Open Market | 75,000 | $3.0M | 12/29/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 47,578 | $1.9M | 12/28/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 35,193 | $1.4M | 12/28/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 26,677 | $1.1M | 12/28/2021 | View on chart |
| RPRX | ▼ Sell | Other | 707,155 | — | 12/28/2021 | View on chart |
| RPRX | ▼ Sell | Other | 407,400 | — | 12/28/2021 | View on chart |
| RPRX | ▼ Sell | Other | 3,212 | — | 12/28/2021 | View on chart |
| RPRX | ▼ Sell | Other | 42,138 | — | 12/28/2021 | View on chart |
| RPRX | ▼ Sell | Other | 150,997 | — | 12/28/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 31,341 | $1.3M | 11/17/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 62,435 | $2.6M | 11/17/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 69,233 | $2.9M | 11/17/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 38,815 | $1.6M | 11/17/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 12,565 | $528K | 11/16/2021 | View on chart |
| RPRX | ▼ Sell | Other | 612,668 | — | 11/16/2021 | View on chart |
| RPRX | ▼ Sell | Other | 219,710 | — | 11/16/2021 | View on chart |
| RPRX | ▼ Sell | Other | 1,028,973 | — | 11/16/2021 | View on chart |
| RPRX | ▼ Sell | Other | 61,338 | — | 11/16/2021 | View on chart |
| RPRX | ▼ Sell | Other | 4,674 | — | 11/16/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 24,648 | $900K | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Other | 2,334 | — | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Other | 5,299 | — | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Other | 8,641 | — | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 34,604 | $1.3M | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Other | 109,814 | — | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 22,173 | $805K | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Other | 511,727 | — | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 7,000 | $257K | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Other | 314,886 | — | 9/29/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 40,000 | $1.5M | 9/28/2021 | View on chart |
| RPRX | ▼ Sell | Open Market | 40,010 | $1.7M | 12/12/2002 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Cibus Partners with Crystal Crop Protection for Mustard Traits
Cibus has agreed to collaborate with Crystal Crop Protection to develop gene-edited traits for mustard crops in India. This partnership aims to improve Brassica Juncea varieties, marking a strategic step in the company's agricultural technology efforts. The stock is currently trading near its 52-week low, with recent technical signals indicating high volatility.
Cibus Partners with Crystal Crop Protection for Mustard Traits. Cibus has agreed to collaborate with Crystal Crop Protection to develop gene-edited traits for mustard crops in India. This partnership aims to improve Brassica Juncea varieties, marking a strategic step in the company's agricultural technology efforts. The stock is currently trading near its 52-week low, with recent technical signals indicating high volatility.